MetLife Investment Management LLC Increases Holdings in Fulcrum Therapeutics, Inc. (NASDAQ:FULC)
MetLife Investment Management LLC increased its stake in Fulcrum Therapeutics, Inc. (NASDAQ:FULC – Free Report) by 145.8% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 40,107 shares of the company’s stock after acquiring an additional 23,792 shares during […]
